News and Events

WHO and St. Jude to dramatically increase global access to childhood cancer medicines
Biggest ever financial commitment to childhood cancer medicines in low- and middle-income countries
The World Health Organization and St. Jude Children’s Research Hospital today announced plans to establish a platform that will dramatically increase access to childhood cancer medicines around the world.
The Global Platform for Access to Childhood Cancer Medicines, the first of its kind, will provide an uninterrupted supply of quality-assured childhood cancer medicines to low- and middle-income countries. St. Jude is making a six-year, US$ 200 million investment to launch the platform, which will provide medicines at no cost to countries participating in the pilot phase. This is the largest financial commitment for a global effort in childhood cancer medicines to date.
Bookmarked
Sign Up to start bookmarking content
Recent
Health4Life Fund. A global financing partnership on non-communicable diseases and mental health
World Health Organization
Third Cycle of the WHO NCD Lab: Tackling obesity through innovation and global action
World Health Organization
Premiere Screening of three videos made by older people (Decade of healthy aging)
World Health Organization